11 Jan FDA approves drug to help with early Alzheimer’s
By Emilie Burditt, Wisconsin Public Radio
The Food and Drug Administration approved a drug called lecanemab to be used for people with early Alzheimer’s in an effort to slow the cognitive decline of the disease. UW Health’s Dr. Nathaniel Chin joins WPR to talk about the drug and the future of Alzheimer’s and dementia-related clinical research.